Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association

Caroline S. Fox, Sherita Hill Golden, Cheryl Anderson, George A. Bray, Lora E. Burke, Ian H. De Boer, Prakash Deedwania, Robert H. Eckel, Abby G. Ershow, Judith Fradkin, Silvio E. Inzucchi, Mikhail Kosiborod, Robert G. Nelson, Mahesh J. Patel, Michael Pignone, Laurie Quinn, Philip R. Schauer, Elizabeth Selvin, Dorothea K. Vafiadis

Research output: Contribution to journalArticlepeer-review

197 Scopus citations

Abstract

Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)691-718
Number of pages28
JournalCirculation
Volume132
Issue number8
DOIs
StatePublished - Aug 25 2015

Keywords

  • AHA Scientific Statements
  • cardiovascular disease
  • diabetes
  • primary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association'. Together they form a unique fingerprint.

Cite this